BridgeBio Pharma to Present at the J.P. Morgan Healthcare Conference

Rhea-AI Summary

BridgeBio Pharma (Nasdaq: BBIO) will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on January 9, 2023, at 3:00 pm PT. The event will feature members of its management team discussing the company's advancements in genetic diseases and cancer treatments. Investors can access a live webcast through the BridgeBio website and a replay will be available for 90 days post-event. Founded in 2015, BridgeBio focuses on developing transformative medicines for patients with genetic conditions and cancer with clear genetic drivers.

PALO ALTO, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced that members of its management team will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Monday, January 9 at 3:00 pm PT.

To access the live webcast of BridgeBio’s presentation, please visit the “Events & Presentations” page within the Investors section of the BridgeBio website at http://investor.bridgebio.com. A replay of the webcast will be available on the BridgeBio website for 90 days following the event.

About BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. (BridgeBio) is a commercial-stage biopharmaceutical company founded to discover, create, test and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. BridgeBio’s pipeline of development programs ranges from early science to advanced clinical trials. BridgeBio was founded in 2015 and its team of experienced drug discoverers, developers and innovators are committed to applying advances in genetic medicine to help patients as quickly as possible. For more information visit bridgebio.com and follow us on LinkedIn and Twitter.

BridgeBio Contact:
Vikram Bali
contact@bridgebio.com
(650)-789-8220

FAQ

When will BridgeBio present at the J.P. Morgan Healthcare Conference?

BridgeBio will present on January 9, 2023, at 3:00 pm PT.

How can I access the BridgeBio presentation webcast?

The live webcast can be accessed via the 'Events & Presentations' page on BridgeBio's investor website.

What is the focus of BridgeBio Pharma?

BridgeBio is focused on developing treatments for genetic diseases and cancers with clear genetic drivers.

What is the history of BridgeBio Pharma?

BridgeBio was founded in 2015 and aims to deliver transformative medicines for patients.

How long will the webcast replay be available?

The replay of the webcast will be available for 90 days following the event.